Drug ID: | NPD7874 |
Drug Name: | Valrubicin |
Molecular Formula: | C34H36F3NO13 |
Canonical SMILES: | CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@@H]2O[C@@H](C)[C@H]([C@H](C2)N=C(C(F)(F)F)O)O)c2c(C1)c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2OC |
Standard InCHI: | InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1 |
Standard InCHIKey: | ZOCKGBMQLCSHFP-KQRAQHLDSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DAP000650 |
DrugBank | DB00385 |
ChEMBL | CHEMBL1096885 |
IUPHAR/BPS | |
PharmaGKB | PA164748616 |
KEGG Drug | |
PubChem CID | |
ChEBI | 135876 |
CAS Number | 56124-62-0 |
Molecular Weight | 723.21 |
ALogP | -2.8852 |
MLogP | 3.33 |
XLogP | 1.053 |
HDA | 11 |
HBD | 5 |
Rotatable Bonds | 23 |
TPSA | 218.71 |
RO5 Violation | 2 |